JUUL Lawsuit Settlement Nets Millions for Schools

Mar.22.2023
JUUL Lawsuit Settlement Nets Millions for Schools
Florida school board approves multi-million dollar settlement from JUUL lawsuit.

On March 21st, according to a report by Fox 13 News, Hillsborough County School Board members in Florida are expected to approve a settlement agreement with JUUL that will include compensation for the school. The funds, which are projected to reach millions of dollars and will be paid over the course of several years, are expected to be approved on Tuesday.


A settlement of $440 million.


In September 2022, the Attorney General of Connecticut announced that JUUL has agreed to pay nearly $440 million to settle over 30 lawsuits from several states concerning their high-nicotine electronic cigarette products. Following this, over 1300 school districts in the United States are currently learning about the settlement amounts they will receive.


To participate in a lawsuit claim, a school district must fulfill two requirements: the school must agree to divide 25% of the compensation with participating lawyers, and the school must provide information about the impact of e-cigarettes in their region.


A series of lawsuits has accused JUUL of using deceptive marketing strategies that target young people and harm their health with nicotine-infused e-cigarettes. The accusations also include school administrators being burdened with financial, time, and resource costs as a result of dealing with student addiction.


Previously, Frederick Hyde, the mayor of Polk County, stated that when school administrators conducted random searches, the item they found most frequently was electronic cigarettes. "Faced with the well-known screening before entering the building, students threw away the most electronic cigarettes in the trash cans in front of the school.


It has been reported that in early March, another Florida-based public school, Orange County, learned that it would receive $5.4 million from the settlement. A member of the Orange County school board stated that they intend to use this money to buy electronic cigarette detectors to protect students. They also plan to offer counseling to students who use e-cigarettes.


JUUL still faces lawsuits to contend with.


Since 2019, JUUL has been maintaining a low profile. It has abandoned all American advertising and removed its fruit and candy flavored e-cigarettes from store shelves.


The FDA took action in June 2022 by issuing a marketing ban on all JUUL products sold in the United States.


Subsequently, JUUL questioned this ruling in court. Afterwards, the FDA conducted a scientific review of the company's technology once again.


According to exclusive information compiled by 2FIRSTS, JUUL has paid a total of $2.6376 billion (approximately 18.2 billion RMB) in settlement funds and is still facing nine independent lawsuits from other states. Additionally, the company is also facing hundreds of individual lawsuits brought forth by teenagers and others.


Related reading:


JUUL has paid $18.2 billion in settlements as part of its effort to resolve ongoing legal issues. This article lists the settlement amounts and conditions in various states.


The American brand Juul will pay $440 million to reach a settlement with various states.


A US district court has approved a $255 million settlement for a class-action lawsuit against Juul prior to the start of the trial.


E-cigarette company JUUL has paid out $1.7 billion in settlements, following lawsuits from 34 different US states.


References:


Hillsborough County schools may be awarded millions of dollars as a result of a lawsuit filed against JUUL.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Special Report | Russia Places Four JTI Businesses Under Temporary Management, a First for Tobacco Majors
Russia has placed shares in four Japan Tobacco International businesses under temporary management, the first such move involving a major global tobacco manufacturer, according to Interfax. JTI held 35.8% of Russia's tobacco market by volume in the first nine months of 2026. While British American Tobacco and Imperial Brands have exited Russia, Philip Morris International continues operating there. As the market changes and diplomatic efforts continue, could international tobacco companies that left Russia eventually return?
Nov.06
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
2Firsts Interview | Cigarette Sales Fall as Smokeless Alternatives Gain in U.S. Convenience Stores, NACS Says
Ahead of the 2026 NACS Show, 2Firsts interviewed Chris Rapanick, NACS managing director of research, on changes reshaping the U.S. convenience-store tobacco and nicotine market. NACS data show cigarette sales declining while smokeless alternatives, including nicotine pouches, continue to grow. The interview also examines higher OTP margins, shifting backbar space, weaker store traffic, regulatory uncertainty and NACS’ outlook for 2027, offering a retailer-side view of one of the world’s largest nicotine markets.
Interview
Oct.03